Ushbu ish iqtibos qilgan ishlar

55 ta ish

Ish: Deformable liposomal codelivery of vorinostat and simvastatin promotes antitumor responses through remodeling tumor microenvironment

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

   Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram +3

   Maqola201834 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.078070

2. Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide

   Xiaopeng Mo, Zening Zheng, Yang He +6

   Maqola20185 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.106260

3. Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy

   Pengfei Zhao, Yonghui Wang, Xuejia Kang +7

   Maqola20184 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.056978

4. Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR^T790M‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery

   Weimin Yin, Xiaolu Yu, Xuejia Kang +7

   Maqola20184 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.056985

5. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

   Douglas Hanahan, Lisa M. Coussens

   Sharh maqola20124 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.095590

6. Reprogramming Tumor-Associated Macrophages To Reverse EGFR^T790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat

   Huige Peng, Binfan Chen, Wei Huang +4

   Maqola20173 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.056975

7. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

   Hongyue Jin, Yang He, Pengfei Zhao +4

   Maqola20183 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.056986

8. Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery

   Binfan Chen, Ang Gao, Bin Tu +7

   Maqola20203 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.057000

9. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

   Dai Fukumura, Jonas Kloepper, Zohreh Amoozgar +2

   Sharh maqola20183 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.082829

10. Immune suppressive mechanisms in the tumor microenvironment

    David H. Munn, Vincenzo Bronte

    Sharh maqola20153 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.121331

11. Targeting macrophages: therapeutic approaches in cancer

    Luca Cassetta, Jeffrey W. Pollard

    Sharh maqola20183 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204069

12. Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan

    W Chen, J Wang, Lianqun Jia +2

    Maqola20162 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.056963

13. Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

    Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera +11

    Maqola20172 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.056969

14. Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy

    Bin Tu, Meng Zhang, Tuanbing Liu +1

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.056999

15. Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery

    Mustafa M.A. Elsayed, Ossama Y. Abdallah, Viviane F. Naggar +1

    Maqola20062 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.057446

16. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

    Sean B. Joseph, Antonio Castrillo, Bryan Laffitte +2

    Maqola20032 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.066091

17. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

    Graziella Solinas, Giovanni Germano, Alberto Mantovani +1

    Sharh maqola20092 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198075

18. VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer

    Magali Terme, Simon Pernot, Elie Marcheteau +7

    Maqola20122 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204054

19. Epigenetic Therapeutics: A New Weapon in the War Against Cancer

    Nita Ahuja, Anup Sharma, Stephen B. Baylin

    Sharh maqola20162 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204059

20. BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR^T790M mutation

    Weimin Yin, Yuge Zhao, Xuejia Kang +5

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204079

21. Macrophage targeting in cancer

    Martha Lopez‐Yrigoyen, Luca Cassetta, Jeffrey W. Pollard

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204080

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204042

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204043

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204044

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.204045